The company has announces the appointment of Magnus Christensen as new CFO of Medivir effective as of 12 August 2019.
Christensen will also join the company’s management team.
In his role, he will be responsible for Investor Relations as well as leading the day-to-day operations within the areas of finance, IT, HR and premises. Magnus Christensen, whose most recent position was as CFO at O’Learys Trademark, has extensive experience of managerial positions within finance from a range of companies.
“I’m delighted to welcome Magnus to Medivir,” says Uli Hacksell, Medivir’s President and CEO. “His personal qualities, experience and competence make Magnus a strong complement to the management team’s expertise within pharmaceutical research and development. We look forward to working with Magnus in building Medivir’s future success.”
